Graft-versus-host disease following ECMO

Robyn M Hatley, M. Reynolds, A. S. Paller, P. Chou

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Since 1973, over 3,000 newborns have been treated worldwide for respiratory failure with extracorporeal membrane oxygenation (ECMO). ECMO requires transfusion of numerous blood products including platelets and packed red blood cells. Transfusion-associated graft-versus-host disease (GVHD) developed in one of the authors' patients following treatment with ECMO. ECMO exposes newborn infants to a large number of blood components. Although a rare complication, GVHD can be prevented by irradiating blood products prior to transfusion. We now irradiate all blood products prior to use during ECMO and recommend that other institutions do the same.

Original languageEnglish (US)
Pages (from-to)317-319
Number of pages3
JournalJournal of Pediatric Surgery
Volume26
Issue number3
DOIs
StatePublished - Jan 1 1991

Fingerprint

Extracorporeal Membrane Oxygenation
Graft vs Host Disease
Newborn Infant
Blood Transfusion
Respiratory Insufficiency
Blood Platelets
Erythrocytes

Keywords

  • Extracorporeal membrane oxygenation (ECMO)
  • graft-versus-host disease

ASJC Scopus subject areas

  • Surgery

Cite this

Graft-versus-host disease following ECMO. / Hatley, Robyn M; Reynolds, M.; Paller, A. S.; Chou, P.

In: Journal of Pediatric Surgery, Vol. 26, No. 3, 01.01.1991, p. 317-319.

Research output: Contribution to journalArticle

Hatley, Robyn M ; Reynolds, M. ; Paller, A. S. ; Chou, P. / Graft-versus-host disease following ECMO. In: Journal of Pediatric Surgery. 1991 ; Vol. 26, No. 3. pp. 317-319.
@article{2c49c4e6b1f44bfe83c5e9bcb8f6e6aa,
title = "Graft-versus-host disease following ECMO",
abstract = "Since 1973, over 3,000 newborns have been treated worldwide for respiratory failure with extracorporeal membrane oxygenation (ECMO). ECMO requires transfusion of numerous blood products including platelets and packed red blood cells. Transfusion-associated graft-versus-host disease (GVHD) developed in one of the authors' patients following treatment with ECMO. ECMO exposes newborn infants to a large number of blood components. Although a rare complication, GVHD can be prevented by irradiating blood products prior to transfusion. We now irradiate all blood products prior to use during ECMO and recommend that other institutions do the same.",
keywords = "Extracorporeal membrane oxygenation (ECMO), graft-versus-host disease",
author = "Hatley, {Robyn M} and M. Reynolds and Paller, {A. S.} and P. Chou",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0022-3468(91)90509-R",
language = "English (US)",
volume = "26",
pages = "317--319",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Graft-versus-host disease following ECMO

AU - Hatley, Robyn M

AU - Reynolds, M.

AU - Paller, A. S.

AU - Chou, P.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Since 1973, over 3,000 newborns have been treated worldwide for respiratory failure with extracorporeal membrane oxygenation (ECMO). ECMO requires transfusion of numerous blood products including platelets and packed red blood cells. Transfusion-associated graft-versus-host disease (GVHD) developed in one of the authors' patients following treatment with ECMO. ECMO exposes newborn infants to a large number of blood components. Although a rare complication, GVHD can be prevented by irradiating blood products prior to transfusion. We now irradiate all blood products prior to use during ECMO and recommend that other institutions do the same.

AB - Since 1973, over 3,000 newborns have been treated worldwide for respiratory failure with extracorporeal membrane oxygenation (ECMO). ECMO requires transfusion of numerous blood products including platelets and packed red blood cells. Transfusion-associated graft-versus-host disease (GVHD) developed in one of the authors' patients following treatment with ECMO. ECMO exposes newborn infants to a large number of blood components. Although a rare complication, GVHD can be prevented by irradiating blood products prior to transfusion. We now irradiate all blood products prior to use during ECMO and recommend that other institutions do the same.

KW - Extracorporeal membrane oxygenation (ECMO)

KW - graft-versus-host disease

UR - http://www.scopus.com/inward/record.url?scp=0025963140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025963140&partnerID=8YFLogxK

U2 - 10.1016/0022-3468(91)90509-R

DO - 10.1016/0022-3468(91)90509-R

M3 - Article

C2 - 2030478

AN - SCOPUS:0025963140

VL - 26

SP - 317

EP - 319

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 3

ER -